Dissociation between muramyl dipeptide-induced fever and changes in plasma metal levels
- PMID: 3963170
- DOI: 10.1152/ajpcell.1986.250.4.C572
Dissociation between muramyl dipeptide-induced fever and changes in plasma metal levels
Abstract
A fall in plasma iron level and an increase in copper level were observed in rabbits subsequent with the febrile response induced by an intravenous administration of muramyl dipeptide, AcMur-L-Ala-D-isoGln (MDP). The pyrogenic activity of MDP was due partly to the induction of circulating endogenous pyrogen (EP). EP produced in vitro by activated macrophages also elicited changes in iron and copper levels in rabbits. Nonpyrogenic MDP derivatives murabutide [MDP(Gln)-OnBu] and the stereoisomer of MDP [MDP(D,D)] did not cause any change in blood metal levels. Another adjuvant and nonpyrogenic analogue, murametide [MDP(Gln)-OMe], elicited hypoferremia and hypercupremia. Murametide, which has been previously shown to induce secretion of circulating EP but prevents in vivo fever response, was unable to prevent an EP-induced effect on plasma metal concentrations. Injection of supernatant fluids of macrophages incubated with these different glycopeptides showed that only compounds able to induce EP release were capable of evoking hypoferremia and hypercupremia. The EP-containing fluid was 10-fold more active on change in temperature and in plasma metal levels when it was given intracerebroventricularly compared with intravenously. In contrast, a pyrogenic dose of MDP that can act directly on the central thermoregulatory structures did not modify iron and copper levels when it was injected intracerebroventricularly.
Similar articles
-
Inhibition of endogenous pyrogen-induced fever by a muramyl dipeptide derivative.Am J Physiol. 1984 Sep;247(3 Pt 1):C169-74. doi: 10.1152/ajpcell.1984.247.3.C169. Am J Physiol. 1984. PMID: 6476105
-
Decrease in pyrogenicity of muramyl dipeptide after coupling with luteinizing hormone-releasing hormone.J Leukoc Biol. 1988 Nov;44(5):448-54. doi: 10.1002/jlb.44.5.448. J Leukoc Biol. 1988. PMID: 3053952
-
Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative.Int J Immunopharmacol. 1982;4(5):451-62. doi: 10.1016/0192-0561(82)90020-0. Int J Immunopharmacol. 1982. PMID: 6982246
-
Muramyl peptides as possible endogenous immunopharmacological mediators.Microbiol Immunol. 1983;27(9):723-32. doi: 10.1111/j.1348-0421.1983.tb00636.x. Microbiol Immunol. 1983. PMID: 6358804 Review.
-
Muramyl peptides and the functions of sleep.Behav Brain Res. 1995 Jul-Aug;69(1-2):85-90. doi: 10.1016/0166-4328(95)00004-d. Behav Brain Res. 1995. PMID: 7546321 Review.
Cited by
-
Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide.Psychopharmacology (Berl). 1989;99(1):103-8. doi: 10.1007/BF00634462. Psychopharmacology (Berl). 1989. PMID: 2506595
-
Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor.Infect Immun. 1988 Jan;56(1):204-12. doi: 10.1128/iai.56.1.204-212.1988. Infect Immun. 1988. PMID: 3275583 Free PMC article.
-
Role of interleukin-1 in augmenting serum neutralization of bacterial lipopolysaccharide.J Clin Microbiol. 1987 May;25(5):889-92. doi: 10.1128/jcm.25.5.889-892.1987. J Clin Microbiol. 1987. PMID: 3495548 Free PMC article.
-
Effect of muramyl peptides on mitochondrial respiration.Clin Exp Immunol. 2009 Jan;155(1):72-8. doi: 10.1111/j.1365-2249.2008.03794.x. Clin Exp Immunol. 2009. PMID: 19076831 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical